SCHEDULE 13D

Company

TherapeuticsMD, Inc.

Filed

July 31, 2009

Accession Number

0001193125-09-160716

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →